✦ LIBER ✦

Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial

✍ Scribed by Saskia Litière; Gustavo Werutsky; Ian S Fentiman; Emiel Rutgers; Marie-Rose Christiaens; Erik Van Limbergen; Margreet HA Baaijens; Jan Bogaerts; Harry Bartelink

Book ID: 117785966
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 327 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70042-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors influencing local relapse and su

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

✍ van Dongen, J.A; Bartelink, H; Fentiman, I.S; Lerut, T; Mignolet, F; Olthuis, G; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 598 KB

Radiotherapy and tamoxifen after mastect

Radiotherapy and tamoxifen after mastectomy in postmenopausal women – 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I

✍ Fredrika Killander; Harald Anderson; Stefan Rydén; Torgil Möller; Knut Aspegren; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 440 KB

Long-term cosmetic changes after breast

Long-term cosmetic changes after breast conserving therapy for patients with stage I and II breast cancer treated in the EORTC “boost versus no boost” trial

✍ M. Immink; H. Putter; J. Visser; H. Bartelink; J. Cardoso; M.J. Cardoso; E.M. No 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Late Toxicity and Patient Self-Assessmen

Late Toxicity and Patient Self-Assessment of Breast Appearance/Satisfaction on RTOG 0319: A Phase 2 Trial of 3-Dimensional Conformal Radiation Therapy-Accelerated Partial Breast Irradiation Following Lumpectomy for Stages I and II Breast Cancer

✍ Wazer, D.E. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Late Toxicity and Patient Self-Assessmen

✍ Chafe, Susan; Moughan, Jennifer; McCormick, Beryl; Wong, John; Pass, Helen; Rabi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Fifteen-year median follow-up results af

Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)

✍ G. G. Kimmick; C. Cirrincione; D. B. Duggan; K. Bhalla; N. Robert; D. Berry; L. 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 325 KB